Cite
MLA Citation
J Naser et al.. “The use of warfarin as part of antithrombotic strategy after transcutaneous aortic valve replacement is not associated with better medium-term outcomes.” European heart journal, vol. 43, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100168329158.0x000046